Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: an unbiased descriptive classification scheme for alzheimer disease biomarkers. Neurology. 2016;87(5):539–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  Google Scholar 

Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of alzheimer’s disease: alzheimer’s association workgroup. Alzheimers Dement. 2024;20(8):5143–69.

Article  PubMed  PubMed Central  Google Scholar 

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.

Article  PubMed  Google Scholar 

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimer’s Dement J Alzheimer’s Assoc. 2011;7(3):263–9.

Article  Google Scholar 

Stocker H, Beyer L, Trares K, Perna L, Rujescu D, Holleczek B, et al. Association of kidney function with development of alzheimer disease and other dementias and dementia-related blood biomarkers. JAMA Netw Open. 2023;6(1):e2252387–e.

Article  PubMed  PubMed Central  Google Scholar 

Mielke MM, Dage JL, Frank RD, Algeciras-Schimnich A, Knopman DS, Lowe VJ, et al. Performance of plasma phosphorylated Tau 181 and 217 in the community. Nat Med. 2022;28(7):1398–405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arslan B, Brum WS, Pola I, Therriault J, Rahmouni N, Stevenson J, et al. The impact of kidney function on alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity. Alzheimers Res Ther. 2025;17(1):48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricardo AC, Flessner MF, Eckfeldt JH, Eggers PW, Franceschini N, Go AS, et al. Prevalence and correlates of CKD in hispanics/latinos in the united States. Clin J Am Soc Nephrol. 2015;10(10):1757–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, et al. Prevalence of hypertension, awareness, treatment, and control in the Hispanic community health study/study of Latinos. Am J Hypertens. 2014;27(6):793–800.

Article  PubMed  PubMed Central  Google Scholar 

Schneiderman N, Llabre M, Cowie CC, Barnhart J, Carnethon M, Gallo LC, et al. Prevalence of diabetes among hispanics/latinos from diverse backgrounds: the Hispanic community health study/study of Latinos (HCHS/SOL). Diabetes Care. 2014;37(8):2233–9.

Article  PubMed  PubMed Central  Google Scholar 

Kim KY, Shin KY, Chang KA. GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Cells. 2023;12(9).

Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, et al. Racial and ethnic estimates of alzheimer’s disease and related dementias in the united States (2015–2060) in adults aged ≥ 65 years. Alzheimers Dement. 2019;15(1):17–24.

Article  PubMed  Google Scholar 

Desai N, Lora CM, Lash JP, Ricardo AC. CKD and ESRD in US Hispanics. Am J Kidney Dis. 2019;73(1):102–11.

Article  PubMed  Google Scholar 

Ricardo AC, Loop MS, Gonzalez F, Lora CM, Chen J, Franceschini N, et al. Incident chronic kidney disease risk among hispanics/latinos in the united states: the Hispanic community health study/study of Latinos (HCHS/SOL). J Am Soc Nephrol. 2020;31(6):1315–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Motolese F, Norata D, Iaccarino G, Sapio E, Capone F. The effect of creatinine level on amyloid-β and Tau plasma concentrations in a cohort of alzheimer’s disease patients without kidney disease. Behav Brain Res. 2025;477:115289.

Article  CAS  PubMed  Google Scholar 

González HM, Tarraf W, Fornage M, González KA, Chai A, Youngblood M, et al. A research framework for cognitive aging and alzheimer’s disease among diverse US latinos: design and implementation of the Hispanic community health study/study of Latinos—Investigation of neurocognitive aging (SOL-INCA). Alzheimer’s Dement. 2019;15(12):1624–32.

Article  Google Scholar 

Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S, Kaplan RC, Daviglus ML, Giachello AL, et al. Design and implementation of the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):629–41.

Article  PubMed  PubMed Central  Google Scholar 

LaVange LM, Kalsbeek WD, Sorlie PD, Avilés-Santa LM, Kaplan RC, Barnhart J, et al. Sample design and cohort selection in the Hispanic community health study/study of Latinos. Ann Epidemiol. 2010;20(8):642–9.

Article  PubMed  PubMed Central  Google Scholar 

Hispanic Community Health Study. About the Study / Public Manuals and Docs, Manual 07 Biospecimen Collection & Processing. [Available from: http://www.cscc.unc.edu/hchs

Wilson DH, Rissin DM, Kan CW, Fournier DR, Piech T, Campbell TG, et al. The Simoa HD-1 analyzer: A novel fully automated digital immunoassay analyzer with Single-Molecule sensitivity and multiplexing. J Lab Autom. 2016;21(4):533–47.

Article  CAS  PubMed  Google Scholar 

Hispanic Community Health Study. About the Study / Public Manuals and Docs, Manual 07a Addendum Central Laboratory Procedures. [Available from: http://www.cscc.unc.edu/hchs

KDIGO. 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013;3(1):136– 50.

WHO. A healthy lifestyle - WHO recommendations 2010 [Available from: https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations

Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13.

Article  Google Scholar 

Tarraf W, Rodríguez C, Daviglus ML, Lamar M, Schneiderman N, Gallo L, et al. Blood pressure and hispanic/latino cognitive function: Hispanic community health study/study of Latinos results. J Alzheimers Dis. 2017;59(1):31–42.

Article  PubMed  PubMed Central  Google Scholar 

Suchy-Dicey AM, Laha T, Hoofnagle A, Newitt R, Sirich TL, Meyer TW, et al. Tubular secretion in CKD. J Am Soc Nephrol. 2016;27(7):2148–55.

Article  CAS  PubMed  Google Scholar 

Gronewold J, Klafki HW, Baldelli E, Kaltwasser B, Seidel UK, Todica O, et al. Factors responsible for plasma β-Amyloid accumulation in chronic kidney disease. Mol Neurobiol. 2016;53(5):3136–45.

Article  CAS  PubMed  Google Scholar 

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and alzheimer’s disease. N Engl J Med. 2002;346(7):476–83.

Article  CAS  PubMed  Google Scholar 

Nantachai G, Vasupanrajit A, Tunvirachaisakul C, Solmi M, Maes M. Oxidative stress and antioxidant defenses in mild cognitive impairment: A systematic review and meta-analysis. Ageing Res Rev. 2022;79:101639.

Article  CAS  PubMed  Google Scholar 

Bos D, Vernooij MW, de Bruijn RF, Koudstaal PJ, Hofman A, Franco OH, et al. Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline. Alzheimers Dement. 2015;11(6):639–e471.

Article  PubMed  Google Scholar 

Zhang B, Zhang C, Wang Y, Chen L, Qiao Y, Wang Y, et al. Effect of renal function on the diagnostic performance of plasma biomarkers for alzheimer’s disease. Front Aging Neurosci. 2023;15:1150510.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lehmann S, Schraen-Maschke S, Vidal JS, Delaby C, Blanc F, Paquet C, et al. Plasma phosphorylated Tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function. J Neurol Neurosurg Psychiatry. 2023;94(6):411–9.

Article  PubMed  Google Scholar 

Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol. 2021;78(12):1471–83.

Article  PubMed